Reports second quarter revenues of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.13) Updates 2025 ...

Turbine, a leading developer of cell simulations with AI, today announced a research collaboration with MSD (the tradename of ...

Recent developments in antiretroviral therapy (ART) include longer-acting therapies that don't require a daily oral pill and ...

The neuroendocrine prostate cancer treatment space will experience significant changes during the forecast period of 2025–2034, owing to the launch o ...

A mum who enrolled in a college course after her son’s type 1 diabetes diagnosis is now building a successful career in science after 20 years ...

Sorbitan Tristearate is projected to dominate the product type segment, commanding a 28% market share by 2025. Its critical ...

Valued at $199.1 billion by market cap, Merck & Co., Inc. (MRK) is a leading American biopharmaceutical company based in ...

Major pharmaceutical companies facing patent cliffs and pipeline gaps may view Viking as an attractive acquisition target if clinical data proves successful. 10 stocks we like better than Viking ...

Biopharma company Jazz Pharmaceuticals (NASDAQ:JAZZ) will be reporting earnings this Tuesday after the bell. Here’s what ...

LONDON, AUG 4 (UNI):- England’s batter Joe Root pays tribute to Graham Thorpe after reaching his 39th Test century against ...

The market’s growth is largely powered by the ongoing advancements and widespread adoption of key technologies, particularly Fluorescent In Situ Hybridization (FISH). In 2025, FISH is estimated to be ...